Showing results (111-120 of 343) with videos related to
Sort By:
Pageof 35
Trends in Neurosciences|February 16, 2010
GARS axonopathy: not every neuron's cup of tRNAWilliam W Motley, Kevin Talbot, Kenneth H FischbeckBrain : a Journal of Neurology|October 31, 2022
Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisalMichael Benatar, Joanne Wuu, Martin R TurnerMuscle & Nerve|November 26, 2013
Tools and talk: an evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosisAndrew Eisen, Martin R Turner, Roger LemonAmyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 21, 2019
Defining pre-symptomatic amyotrophic lateral sclerosisMichael Benatar, Martin R Turner, Joanne WuuPractical Neurology|May 19, 2009
When to consider thyroid dysfunction in the neurology clinicNiraj Mistry, John Wass, Martin R TurnerNature Reviews. Neurology|October 13, 2011
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitationsRobert Bowser, Martin R Turner, Jeremy ShefnerFrontiers in Neurology|January 24, 2019
Imaging Cerebral Activity in Amyotrophic Lateral SclerosisMalcolm Proudfoot, Peter Bede, Martin R TurnerCurrent Opinion in Neurology|June 29, 2023
Presymptomatic amyotrophic lateral sclerosis: from characterization to preventionMichael Benatar, Martin R Turner, Joanne WuuAnnals of Neurology|November 16, 2024
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion CarriersElizabeth R Dellar, Iolanda Vendrell, Benazir Amein, et al.Toxins|October 24, 2020
Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron DiseaseMireia Herrando-Grabulosa, Caty Casas, Kevin Talbot, et al.Pageof 35